Management of Viral Dry Cough in Elderly: Evidence‑Based Recommendations

First‑Line Supportive Care (Days 1–14)

• Recommend honey for patients ≥ 1 year of age as the initial intervention because it provides symptomatic relief through central modulation of the cough reflex. 1
• Advise patients to avoid lying flat on their back, a position that worsens cough effectiveness and aggravates symptoms. 1
• Encourage adequate hydration (≈ ≤ 2 L / day) to prevent dehydration, especially when fever is present. 1
• Use paracetamol rather than NSAIDs for fever and associated symptoms, continuing only while symptoms persist. 1

Assessment for Serious Pathology

• Elderly individuals with comorbidities, frailty, or impaired immunity have a higher risk of developing severe pneumonia that can progress to respiratory failure and death. 1
• Obtain a chest radiograph immediately when any of the following are present: new focal chest signs, dyspnea, tachypnea, pulse > 100 bpm, fever lasting > 4 days, or respiratory rate > 30 breaths/min. 2
• The presence of focal auscultatory abnormalities (crackles, diminished breath sounds, dullness) raises the probability of pneumonia from 5–10 % to ≈ 39 %. 2
• In patients ≥ 65 years, assess for risk factors predicting a complicated course of pneumonia: COPD, diabetes, heart failure, recent hospitalization, oral glucocorticoid use, confusion, or systolic BP < 90 mm Hg. 2

Second‑Line Pharmacologic Treatment (Weeks 1–3)

• If cough persists beyond 1–2 weeks and significantly impairs quality of life, prescribe inhaled ipratropium bromide 2–3 puffs (17–34 µg per puff) four times daily. 1
• Ipratropium attenuates post‑infectious cough by reducing mucus hypersecretion and decreasing airway irritability that persists after viral infection. 3

Upper Airway Management (When Upper Airway Symptoms Present)

• Prescribe a first‑generation antihistamine/decongestant combination (e.g., brompheniramine/pseudoephedrine) to address throat clearing, post‑nasal drip, or nasal congestion. 4
• Note that newer “non‑sedating” antihistamines (loratadine, terfenadine) are ineffective for post‑viral cough; the anticholinergic properties of first‑generation agents are essential for efficacy. 4

Severe Cases and Corticosteroid Use

• Reserve short‑term oral prednisone (30–40 mg daily for 5–10 days) for severe paroxysmal cough that markedly impairs quality of life, after excluding upper airway cough syndrome, asthma, and gastro‑oesophageal reflux disease. 1

Antitussive Agents for Distressing Dry Cough

• Consider short‑term use of codeine linctus, codeine phosphate tablets, or morphine sulfate oral solution to suppress a distressing dry cough. 1

Do‑Not‑Do: Critical Pitfalls

• Do not prescribe antibiotics for viral or post‑infectious cough; they provide no benefit, promote antimicrobial resistance, and cause unnecessary adverse effects. 5
• Do not use antipyretics solely to lower body temperature; they should be employed only when fever causes discomfort or is associated with other symptoms. 1

Reassessment and Transition to Chronic Cough Management

• If cough persists beyond 8 weeks, reclassify it as chronic cough and systematically evaluate for upper airway cough syndrome, asthma, and gastro‑oesophageal reflux disease. 6

Special Considerations for Elderly Patients

• Monitor closely for rapid deterioration; elderly patients can develop severe pneumonia quickly, potentially leading to respiratory failure. 1
• Assess for left‑ventricular failure in patients > 65 years who present with orthopnea, displaced apex beat, or a history of myocardial infarction, hypertension, or atrial fibrillation. 2
• Consider pulmonary embolism in patients with a history of deep‑vein thrombosis, recent immobilization (past 4 weeks), or active malignancy. 2
• Evaluate for aspiration pneumonia in patients with swallowing difficulties who exhibit signs of acute lower respiratory tract infection. 2

Management of Persistent Dry Cough After Failed Antibiotic Therapy

Diagnostic Steps

• Obtain a chest radiograph to rule out persistent pneumonia, masses, interstitial disease, or congestive heart failure in patients with chronic cough (>3 weeks duration) 7
• The patient's cough has persisted for at least 5 weeks total, qualifying as subacute cough (3-8 weeks) 8

Most Likely Diagnosis: Post-Infectious Cough with UACS

• The clinical presentation—dry persistent cough following respiratory infection that failed to resolve with antibiotics—strongly suggests post-infectious cough and/or upper airway cough syndrome 8
• Multiple pathogenetic factors contribute: postviral airway inflammation, bronchial hyperresponsiveness, mucus hypersecretion, and impaired mucociliary clearance 9, 8

First-Line Treatment Protocol

• Prescribe a first-generation antihistamine/decongestant combination (e.g., brompheniramine/pseudoephedrine or chlorpheniramine/phenylephrine) 8, 7
• Begin with once-daily bedtime dosing for 2-3 days, then advance to twice-daily to minimize sedation 8
• Add intranasal corticosteroid spray (e.g., fluticasone, mometasone) to decrease airway inflammation 8

Second-Line Options if No Improvement in 1-2 Weeks

• Trial inhaled ipratropium bromide 2-3 puffs four times daily, which has been shown to attenuate post-infectious cough with fewer systemic side effects 9, 8
• Consider inhaled corticosteroids (e.g., budesonide, fluticasone) if cough persists and adversely affects quality of life 9, 8
• Prescribe prednisone 30-40 mg daily for 5-7 days only after ruling out other causes (asthma, GERD) 9, 7
• Add central-acting antitussives (codeine 15-30 mg or dextromethorphan 30 mg every 6 hours) when other measures fail 9, 8

Systematic Evaluation if Treatment Fails

• After 2 weeks of adequate UACS therapy without improvement, evaluate sequentially for asthma/non-asthmatic eosinophilic bronchitis and GERD 10, 7
• If both UACS and asthma treatments fail, initiate high-dose PPI therapy (e.g., omeprazole 40 mg twice daily), dietary modifications, and lifestyle changes 10, 7
• GERD-related cough may require 2 weeks to several months for response, with some patients needing 8-12 weeks 10, 7

Advanced Testing if All Empiric Therapy Fails

• Order high-resolution CT chest to evaluate for bronchiectasis, interstitial lung disease, or occult masses 10, 7
• Consider bronchoscopy to evaluate for endobronchial lesions, sarcoidosis, eosinophilic bronchitis, or occult infection 10, 7
• Order 24-hour esophageal pH monitoring if GERD remains suspected despite failed empiric therapy 10, 7

Critical Pitfalls to Avoid

• Do not repeat antibiotics—this patient already failed azithromycin, and post-infectious cough is not bacterial 9
• Do not use nasal decongestant sprays >3-5 days due to rebound congestion risk 8
• Do not diagnose "unexplained cough" until completing systematic evaluation of UACS, asthma, and GERD with adequate treatment trials 7
• Pertussis should be considered if paroxysmal cough with post-tussive vomiting or inspiratory whoop develops, though this is less likely given the clinical picture 9